21 results
8-K
3svu kyvf
16 Jun 21
Satsuma Pharmaceuticals Announces Positive Pharmacokinetic, Tolerability and Safety Results From Phase 1 Trial of STS101 at Multiple Dose Strengths
4:29pm
8-K
EX-99.2
s0wyct0 6fin2m
1 Mar 21
Satsuma Pharmaceuticals Announces Updated STS101 Development Plan
12:00am
10-K
3ugear oxr
10 Mar 20
Annual report
4:20pm
10-Q
1wjv2z3
12 Nov 19
Quarterly report
4:31pm
424B4
3hr1v1k49iysat xefd
13 Sep 19
Prospectus supplement with pricing info
5:08pm
S-1/A
zka4zmbz
3 Sep 19
IPO registration (amended)
6:12am
S-1
nps u9xxxbtcp3c
16 Aug 19
IPO registration
5:15pm
DRS/A
xxx78qpnbuyhgjq3 r9
2 Aug 19
Draft registration statement (amended)
12:00am